Medicare patients with multiple sclerosis face skyrocketing costs for treatment due to insurance regulations that force them to pay more out of pocket for generic drugs, a study has found.
May 9, 2012 -- It is relatively common for doctors to diagnose someone
with multiple sclerosis when the patient doesn't have the disease — a
misdiagnosis that not only causes patients potential harm but costs the
U.S. health care system untold millions of dollars a year, according to a
study published online today in the journal Neurology.
The study is based on a survey of 122 multiple sclerosis specialists
nationwide and was conducted by researchers at Oregon Health
& Science University and the Portland Veterans Affairs Medical